ChronoScale Corporation Common Stock (NASDAQ:CHRN) Sees Significant Growth in Short Interest

ChronoScale Corporation Common Stock (NASDAQ:CHRN) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totaling 424,399 shares, an increase of 135.1% from the April 30th total of 180,534 shares. Currently, 12.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 420,857 shares, the days-to-cover ratio is currently 1.0 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $6.00.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

A number of large investors have recently modified their holdings of the stock. Consolidated Portfolio Review Corp bought a new stake in ChronoScale Corporation Common Stock during the 3rd quarter valued at approximately $333,000. Geode Capital Management LLC raised its holdings in ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares in the last quarter. Citadel Advisors LLC purchased a new position in ChronoScale Corporation Common Stock during the third quarter valued at $198,000. Shay Capital LLC purchased a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth about $67,000. Finally, Virtu Financial LLC bought a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth approximately $57,000. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Trading Up 0.4%

Shares of NASDAQ:CHRN traded up $0.07 during trading on Friday, reaching $18.36. 177,507 shares of the company traded hands, compared to its average volume of 378,210. The firm has a market capitalization of $65.36 million, a price-to-earnings ratio of -3.41 and a beta of 0.86. The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25. The business’s fifty day moving average is $12.34 and its 200-day moving average is $9.38. ChronoScale Corporation Common Stock has a 52-week low of $2.73 and a 52-week high of $20.70.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings data on Tuesday, April 28th. The company reported ($2.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($2.01). The firm had revenue of $2.14 million for the quarter, compared to the consensus estimate of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. As a group, analysts forecast that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.